bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.08.14.670271

Female sex hormones enhance gonococcal colonization at the endocervix by modifying cervical mucus

Abstract

Neisseria gonorrhoeae is a human-exclusive pathogen that causes gonorrhea. Gonococci (GC) initiate female infections by colonizing the cervix, which can remain asymptomatic, cause cervicitis, or ascend to the upper female reproductive tract (FRT), leading to severe tissue damage. The FRT undergoes sex hormone-mediated changes during the menstrual cycle, which have long been implicated in the vulnerability to GC infection. One of the major changes is the increase and decrease in the production of the gel-forming mucin MUC5B by the endocervix in response to the level of estradiol (E2). This study examined the impact of sex hormones on GC infection of the human cervix, utilizing a human cervical tissue explant model. Tissue explants were treated without and with E2 alone or in combination with progesterone (E2+P4) to mimic various menstrual cycle phases. Treatment of E2 or E2+P4 enhanced GC colonization at the endocervix exclusively, but did not affect epithelial transmigration. While both treatments increased the number of GC microcolonies, E2+P4 increased GC colony size on the endocervical epithelium. These increases were independent of GC host receptors, carcinoembryonic antigen-related cell adhesion molecules. GC effectively diffused through cervical mucus to interact with the cervical epithelium under all hormone conditions and through mucin hydrogels with different MUC5B and MUC5AC compositions. Mucus gels collected from cervical explants and animal mucin mixtures enhanced GC aggregation in vitro. GC diffusion through mucin-hydrogels and aggregation in the presence of cervical mucus or animal mucins decreased as the MUC5B concentration increased. Our results suggest that female sex hormones promote GC colonization at the human endocervix by modulating the cervical mucus production, regulating womens susceptibility to GC infection, and further reveal the ability of GC to evade the mucus defense barrier for infection. Author SummaryNeisseria gonorrhoeae is a bacterial pathogen that primarily infects the human genital and female reproductive tracts, causing gonorrhea. While this bacterium can infect both men and women, the infection can lead to severe and permanent damage to womens reproductive systems. Currently, the relationship of gonococcal infection with the menstrual cycle is unknown. Here, we utilize a human cervical tissue explant model that mimics gonococcal infection in women to examine the impact of female sex hormones that drive the menstrual cycle on gonococcal infection. We found that estrogen alone or in combination with progesterone enhanced gonococcal colonization, increasing both the number and size of bacterial microcolonies on the cervical luminal surface, through regulating mucus production. Gonococci effectively penetrate through mucus layers to reach cervical epithelial cells and also prefer to aggregate with each other in the presence of mucus. Our results reveal that hormone-regulated mucus production changes the vulnerability of women to gonococcal infection, and that gonococci convert the mucus defense barrier into a colonization facilitator.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Di Benigno, S., Edwards, V., Mathur, S., Boboltz, A., Engle, E., Kaler, L., Scull, M., Duncan, G., Wang, L.-C., Stein, D., Song, W.. 2025-08-14. Female sex hormones enhance gonococcal colonization at the endocervix by modifying cervical mucus. https://doi.org/10.1101/2025.08.14.670271

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Reverse Transcription Loop-Mediated Isothermal Amplification Combined with Lateral Flow Assay (RT-LAMP-LFA) for Rapid Detection of the 2026 Bundibugyo Virus (BDBV) Outbreak Strain

Making accurate diagnosis is a critical first step in patient management and control for emerging and re-emerging disease outbreaks. Bundibugyo virus (BDBV) is a filovirus that causes Ebola disease, and the 2026 outbreak highlights the need for rapid diagnostic approaches that can be deployed in settings with limited laboratory infrastructure. Here, we developed a reverse transcription loop-mediated isothermal amplification-lateral flow assay (RT-LAMP-LFA) for rapid detection of the 2026 BDBV outbreak strain. LAMP primers were designed based on the genome sequence of the 2026 outbreak strain, and the conservation of the primer binding sites among all available 2026 outbreak genomes was confirmed in silico. LAMP primers were evaluated for analytical specificity and sensitivity using in vitro-transcribed RNA (ivtRNA) from BDBV and other filoviruses, as well as RNA derived from arboviruses and mammalian cells. Amplification products were detected using a Chromatography-Printed Array Strip (C-PAS) lateral flow platform. The newly designed primers specifically detected the presence of BDBV RNA without nonspecific amplification of the other viral or cellular RNA samples tested. Consistent amplification was observed down to 103 copies per reaction. In addition, BDBV viral RNA was successfully amplified, and the amplification products were detected using C-PAS, with the total workflow being completed within 25 min. These findings demonstrate the analytical specificity and sensitivity of the developed RT-LAMP-LFA assay and its compatibility with rapid visual lateral flow detection, supporting its potential application as a point-of-care approach for BDBV detection.

microbiology↗

Divergent methane production and microbial community responses to carbon enrichment in freshwater wetland sediments

Methane (CH4) accumulation in wetland sediments reflects interactions among organic matter, sediment chemistry, and microbial communities. We combined depth-resolved field characterization across four wetland habitats in northern Israel with complementary incubations to examine methane accumulation and responses to labile-carbon enrichment. Sediment cores were characterized using Rock-Eval analysis, porewater chemistry, oxygen profiling at three sites, and mcrA amplicon sequencing. High CH4 concentrations occurred under contrasting conditions: Ein Nimfit (EN) contained approximately 12% total organic carbon and reached 2.1 mM CH4, whereas Ein Afek site EA2 contained approximately 5% carbon and accumulated 0.7-1.7 mM CH4. Both showed sulfate depletion, but EN exhibited pronounced sulfide accumulation, whereas EA2 showed greater dissolved iron and nutrient enrichment. Their classified methanogenic assemblages also differed. EA1 remained methane poor despite increasing carbon content with depth, while EA3 combined low carbon content and CH4 accumulation with detectable methanogens and lower methanogenic diversity. In a 36-day bottle experiments using sediments from two of the four wetland habitats, sucrose-amended EA3 exhibited a transient maximum of 18.8 mmol collected CH4 kg-1 wet sediment during Days 22-29, whereas EN reached its highest collected amount during Days 29-36. Methane proportions increased before the large output increase in EA3 but remained comparatively stable and high in EN. Soluble chemical oxygen demand trajectories and microbial community changes also differed. These findings identify distinct biogeochemical settings supporting methane accumulation and demonstrate methanogenic potential in low-CH4 sediment, emphasizing the complementary information provided by field profiles, microbial characterization, and exploratory enrichment experiments.

microbiology↗

The absence of microbiome in germ-free mice exacerbates the pathogenicity of mouse-adapted SARS-CoV-2 MA10

Germ-free mice, which are devoid of microbiota, provide a powerful system to define the contribution of the microbiome to host responses during infection. Severe COVID-19 outcomes are associated with multiple comorbidities that are themselves characterized by microbiome dysbiosis; however, the causal role of the microbiota in SARS-CoV-2 pathogenesis remains poorly understood. Here, we use germ-free mouse models to evaluate the impact of the microbiome on disease severity following infection with mouse-adapted SARS-CoV-2 MA10. Comparison with conventionally housed mice revealed that the absence of the microbiome markedly exacerbates SARS-CoV-2-induced disease in both C57BL/6 and Swiss Webster backgrounds. Germ-free mice exhibited greater weight loss, impaired lung function, worsened pulmonary pathology, and pronounced alterations in circulating cytokine and chemokine profiles compared with conventional controls. These findings show that resident microbiota limit SARS-CoV-2 pathogenicity and establish germ-free COVID-19 models as a powerful platform to identify protective microbial taxa and microbiota-based interventions to reduce severe disease.

microbiology↗